Literature DB >> 19248675

Arteriovenous malformation radiosurgery: a twenty year perspective.

L Dade Lunsford1, Ajay Niranjan, Douglas Kondziolka, Sait Sirin, J C Flickinger.   

Abstract

Mesh：

Year:  2008        PMID： 19248675

Source DB:  PubMed          Journal:  Clin Neurosurg        ISSN： 0069-4827


× No keyword cloud information.
  7 in total

Review 1.  Cranial stereotactic radiosurgery: current status of the initial paradigm shifter.

Authors:  Jason P Sheehan; Chun-Po Yen; Cheng-Chia Lee; Jay S Loeffler
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

Review 2.  Modern robot-assisted radiosurgery of cerebral angiomas-own experiences, system comparisons, and comprehensive literature overview.

Authors:  Thomas Feutren; Andres Huertas; Julia Salleron; René Anxionnat; Serge Bracard; Olivier Klein; Didier Peiffert; Valérie Bernier-Chastagner
Journal:  Neurosurg Rev       Date:  2017-11-05       Impact factor: 3.042

3.  National trends in inpatient admissions following stereotactic radiosurgery and the in-hospital patient outcomes in the United States from 1998 to 2011.

Authors:  Allen L Ho; Alexander Y Li; Eric S Sussman; Arjun V Pendharkar; Aditya Iyer; Patricia A Thompson; Armine T Tayag; Steven D Chang
Journal:  J Radiosurg SBRT       Date:  2016

4.  Multistage stereotactic radiosurgery for large cerebral arteriovenous malformations using the Gamma Knife platform.

Authors:  Chuxiong Ding; Brian Hrycushko; Louis Whitworth; Xiang Li; Lucien Nedzi; Bradley Weprin; Ramzi Abdulrahman; Babu Welch; Steve B Jiang; Zabi Wardak; Robert D Timmerman
Journal:  Med Phys       Date:  2017-08-12       Impact factor: 4.071

5.  Morphological changes after radiosurgery for mesial temporal lobe epilepsy.

Authors:  Zdeněk Vojtěch; Hana Malíková; Martin Syrůček; Lenka Krámská; Jan Šroubek; Vilibald Vladyka; Roman Liščák
Journal:  Acta Neurochir (Wien)       Date:  2015-08-16       Impact factor: 2.216

6.  Identification of protein targets in cerebral endothelial cells for brain arteriovenous malformation (AVMs) molecular therapies.

Authors:  Margaret Simonian; Rachel R Ogorzalek Loo; Nalaka Rannulu; Joseph A Loo; Mark P Molloy; Marcus A Stoodley
Journal:  Clin Proteomics       Date:  2017-05-16       Impact factor: 3.988

7.  Benefits of Treating Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia: A Retrospective Analysis of 14 Patients.

Authors:  M Neil Woodall; Peter Nakaji; Robert F Spetzler
Journal:  World Neurosurg X       Date:  2019-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.